Ginkgo BioWorks

Enzymatic biocatalysis is a manufacturing technology that can enable the production of a wide range of chemicals and molecules.

Zymtronix Partners with Ginkgo Bioworks to Produce Enzymes for Industrialization of Cell-Free Biomanufacturing

Enzymatic biocatalysis is a manufacturing technology that can enable the production of a wide range of chemicals and molecules.

The executive order will accelerate the use of biotech in agriculture, medicine and energy as an alternative to fossil fuel-based products.

Executive Order: President Biden Supports Biotech with Appointment of Wegrzyn

The executive order will accelerate the use of biotech in agriculture, medicine and energy as an alternative to fossil fuel-based products.

Ginkgo hopes to use FGen's technology to routinely analyze the performance of millions of pooled genetic prototypes.

Ginkgo Acquires FGen AG

With the transaction, Ginkgo will utilize FGen’s ultra-high-throughput platform to enhance its cell screening capabilities.

Cronos Group and Ginkgo Bioworks amended their agreement to accelerate the commercialization of cultured cannabinoids as Cronos begins commercial production of CBG.

Cronos Group and Ginkgo Bioworks to Accelerate CBG Production

Cronos Group and Ginkgo Bioworks amended their agreement to accelerate the commercialization of cultured cannabinoids as Cronos begins the production of CBG.

Ginko Bioworks Moderna

Ginkgo Bioworks’ Materials Support mRNA Vaccine

To support researchers and manufacturers toward the prevention of COVID-19, Ginkgo Bioworks has teamed up with Moderna for the processing and testing of an mRNA vaccine, mRNA-1273.